Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | -21.38% | -19.01% | -9.08% | -10.53% | -1.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.38% | -19.01% | -9.08% | -10.53% | -1.51% |
| Cost of Revenue | -23.64% | -19.08% | -10.92% | -2.43% | 11.05% |
| Gross Profit | -17.72% | -18.89% | -6.16% | -21.15% | -16.78% |
| SG&A Expenses | -17.37% | -5.90% | 4.50% | 15.08% | 15.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.20% | -13.20% | -4.15% | 4.68% | 12.63% |
| Operating Income | 7.38% | -92.39% | -102.47% | -446.78% | -300.42% |
| Income Before Tax | -3.53% | -54.64% | -60.05% | -766.56% | -1,215.92% |
| Income Tax Expenses | -- | -100.00% | -100.00% | -100.00% | -95.32% |
| Earnings from Continuing Operations | -3.04% | -51.87% | -48.24% | -415.69% | -463.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.04% | -51.87% | -48.24% | -415.69% | -463.34% |
| EBIT | 7.38% | -92.39% | -102.47% | -446.78% | -300.42% |
| EBITDA | 4.63% | -256.41% | -355.99% | -229.22% | -171.77% |
| EPS Basic | -2.81% | -51.49% | -47.93% | -417.29% | -463.37% |
| Normalized Basic EPS | -2.82% | -53.53% | -58.58% | -618.33% | -859.46% |
| EPS Diluted | -9.54% | -68.88% | -62.77% | -430.83% | -414.91% |
| Normalized Diluted EPS | -2.82% | -53.53% | -58.58% | -618.33% | -859.46% |
| Average Basic Shares Outstanding | 0.13% | 0.13% | 0.13% | 0.12% | 0.14% |
| Average Diluted Shares Outstanding | 0.13% | 0.13% | 0.13% | 0.12% | 0.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
